CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.

Liu Q, Liu H, Sacco P, Djaker N, Lamy de la Chapelle M, Marsich E, Li X, Spadavecchia J.

DOI: 10.1039/d0na00758g
Published: 2020-09-29
Container: Nanoscale Adv
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 4/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/d0na00758g,
  title = {CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.},
  author = {Liu Q and  Liu H and  Sacco P and  Djaker N and  Lamy de la Chapelle M and  Marsich E and  Li X and  Spadavecchia J.},
  year = {2020},
  journal = {Nanoscale Adv},
  doi = {10.1039/d0na00758g},
  url = {https://doi.org/10.1039/d0na00758g}
}

RIS

TY  - JOUR
TI  - CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.
AU  - Liu Q
AU  -  Liu H
AU  -  Sacco P
AU  -  Djaker N
AU  -  Lamy de la Chapelle M
AU  -  Marsich E
AU  -  Li X
AU  -  Spadavecchia J.
PY  - 2020
JO  - Nanoscale Adv
DO  - 10.1039/d0na00758g
UR  - https://doi.org/10.1039/d0na00758g
ER  -

APA

Q, L., H, L., P, S., N, D., M, L. D. L. C., E, M., X, L., & J., S. (2020). CTL-doxorubicin (DOX)-gold complex nanoparticles (DOX-AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model.. Nanoscale Adv. https://doi.org/10.1039/d0na00758g

Source records

europe-pmc · retrieved 2026-09-25T04:11:58.181Z